Express & Expedited Shipping Service
USD $16.20
IndiaBIDIL is a prescription medication that combines isosorbide dinitrate and hydralazine. It is primarily used to treat heart failure in specific populations, particularly African American patients. This unique combination works to relax blood vessels, improve blood flow, and reduce the workload on the heart.
The isosorbide dinitrate component dilates blood vessels, which helps to decrease blood pressure and reduce the heart's oxygen demand. Hydralazine, on the other hand, acts as a vasodilator that further aids in lowering blood pressure and improving circulation.
BIDIL is indicated for the treatment of heart failure in conjunction with other medications. It is particularly beneficial for patients who may not respond adequately to standard therapies.
The dosage of BIDIL is individualized based on the patient's response and clinical condition. It is important to follow the prescribing physician's instructions regarding dosage and administration to achieve optimal results.
Common side effects of BIDIL may include headache, dizziness, and gastrointestinal disturbances. More serious side effects can occur, and patients should be monitored for signs of hypotension or allergic reactions.
Before starting BIDIL, patients should inform their healthcare provider of any pre-existing conditions, allergies, or other medications they are taking. Special caution is advised for those with a history of heart conditions or low blood pressure.
BIDIL represents an important treatment option for heart failure, particularly in African American patients. Its combination of isosorbide dinitrate and hydralazine targets multiple pathways involved in heart function, making it a valuable addition to heart failure management strategies.
Health Guides
Oct 20, 2026
Methimazole for hyperthyroidism reduces excess thyroid hormone production without destroying the thyroid gland. Treatment usually starts with a higher dose, followed by blood-test-guided reductions as hormone levels return to normal. This guide to methimazole hyperthyroidism treatment covers testing
Oct 19, 2026
Atrial fibrillation medications address three goals: rate control for a fast heart rate, rhythm control for an abnormal rhythm, and stroke prevention with anticoagulants that reduce blood clots. For atrial fibrillation, the regimen depends on stroke risk, heart and kidney function, and other prescri
Oct 17, 2026
Heart failure medications reduce strain on the heart, control fluid buildup, and lower the risk of hospitalization. Several drug classes also improve survival in people with reduced ejection fraction, although medicines don't cure heart failure. Treatment usually combines medicines because each addr
Oct 16, 2026
SGLT2 inhibitors lower blood glucose by helping the kidneys remove glucose through urine. Selected medicines also reduce heart-failure events and slow chronic kidney disease progression, so prescribing decisions extend beyond blood sugar alone. The short answer: SGLT2 inhibitors can benefit people
Oct 15, 2026
Potassium salt substitutes can lower sodium intake and blood pressure, but some hypertension medicines make the extra potassium unsafe. The main concern is hyperkalemia, an elevated blood potassium level that can disturb the heart's rhythm. Safety depends on kidney function, the complete medication
Oct 13, 2026
A COPD diagnosis often leads to several prescriptions, each with a different job. A rescue inhaler eases sudden breathing symptoms. Long-acting bronchodilators are taken daily to control breathlessness and reduce exacerbations. Inhaled corticosteroids may be prescribed for people with recurrent fla
Oct 07, 2026
A medicine that prevents a stroke can also increase surgical bleeding, while stopping it can raise the risk of a clot. Preparing medications before surgery requires a written, individualized plan, not a blanket instruction to stop daily prescriptions. The short answer: Give the surgical team a comp
Oct 06, 2026
A warfarin INR test helps clinicians assess whether treatment provides enough protection against blood clots while limiting bleeding risks. The target INR range is individualized, though many patients have a target of 2.0 to 3.0. An out-of-range result should be interpreted alongside symptoms, recen
Oct 04, 2026
Grapefruit can change how much medication reaches the bloodstream, even when the prescribed dose stays the same. Grapefruit drug interactions affect certain cholesterol, blood pressure, transplant, cancer, and allergy medicines, but the risk depends on the exact medicine. For some drugs, exposure ri
Oct 02, 2026
Common painkillers and herbal supplements can interact with blood thinners. Depending on the medicines involved and the patient, these blood thinner interactions may increase bleeding or reduce protection against blood clots. Ibuprofen, naproxen, aspirin, and certain supplements need review before
